(Q36895942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Interactions between protease inhibitors and acid-reducing agents: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Béïque L

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Giguère P

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

la Porte C

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

335-345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661841%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetic interaction between ritonavir and didanosine when administered concurrently to HIV-infected patients

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Importance of pH control in the management of GERD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Pharmacogenetics of the proton pump inhibitors: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Pharmacologic properties of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

An update on therapeutic drug monitoring for antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Proton pump inhibitors do not reduce atazanavir concentrations in HIV-infected patients treated with ritonavir-boosted atazanavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X

Co-administration of atazanavir with proton-pump inhibitors and H2 blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00482.X